STAAR Surgical

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The Company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.
Company Growth (employees)
Type
Public
HQ
Monrovia, US
Founded
1982
Size (employees)
336 (est)
Website
staar.com
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US

STAAR Surgical Office Locations

STAAR Surgical has offices in Monrovia, Nidau and Tustin
Monrovia, US (HQ)
1911 Walker Ave
Nidau, CH
104 Hauptstrasse

STAAR Surgical Financials and Metrics

STAAR Surgical Financials

STAAR Surgical's revenue was reported to be $20.4 m in Q1, 2017
USD

Revenue (Q1, 2017)

20.4 m

Gross profit (Q1, 2017)

14.6 m

Gross profit margin (Q1, 2017), %

72%

Net income (Q1, 2017)

(2.2 m)

EBIT (Q1, 2017)

(2.1 m)

Market capitalization (17-Oct-2017)

534.2 m

Cash (31-Mar-2017)

13.5 m
STAAR Surgical's current market capitalization is $534.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

72.2 m75 m77.1 m82.4 m

Revenue growth, %

4%3%7%

Cost of goods sold

21.9 m26.2 m24.4 m24.1 m

Gross profit

50.3 m48.8 m52.7 m58.4 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2016Q1, 2017

Revenue

20 m18.2 m18.9 m18.7 m18.8 m19.3 m21 m20.1 m20.4 m

Cost of goods sold

6.4 m6.3 m6 m6.3 m6 m6.3 m6.3 m5.2 m5.8 m

Gross profit

13.7 m11.9 m12.9 m12.4 m12.8 m13 m14.6 m14.9 m14.6 m

Gross profit Margin, %

68%65%68%66%68%67%70%74%72%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

23 m13 m13.4 m14 m

Accounts Receivable

10.7 k11.1 k15.7 k16.3 k

Inventories

12.5 k15.7 k15.9 k14.8 m

Current Assets

50.1 m44.9 m49.1 m49.9 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2016Q1, 2017

Cash

19.2 m18.4 m10.8 m15.3 m16.1 m9 m12.7 m14.3 m13.5 m

Inventories

14.9 m15.7 m15.3 m14.2 m14.6 m16 m15.7 m15.9 m14.6 m

Current Assets

50.7 m49.4 m43 m46.6 m48.1 m46.2 m48.9 m49.7 m49 m

PP&E

9.3 m9.3 m9.9 m9.9 m9.9 m11 m11.4 m11.7 m12.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

398 k(8.4 m)(6.5 m)(12.1 m)

Depreciation and Amortization

1.7 m2.1 m2.2 m2.7 m

Accounts Receivable

(2.9 m)(934 k)(5 m)(771 k)

Inventories

(1.6 m)(3.9 m)327 k1.8 m
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2016Q1, 2017

Net Income

(1.8 m)(2.7 m)(2.3 m)(1.6 m)(1.8 m)(8 m)(2.1 m)(1.8 m)(2.2 m)

Accounts Payable

5.3 m6.3 m4.9 m4.8 m5.8 m6.9 m8.7 m8 m7.6 m
USDY, 2017

Revenue/Employee

60.6 k

Financial Leverage

1.8 x
Show all financial metrics

STAAR Surgical Operating Metrics

FY, 2016

Patents Issued

67

Patents Pending

20

Trademarks

11
Show all operating metrics

STAAR Surgical Market Value History

STAAR Surgical Revenue Breakdown

Traffic Overview of STAAR Surgical

STAAR Surgical Online and Social Media Presence

STAAR Surgical Company Life and Culture

You may also be interested in